Current Research Funding:
(1) Molecular Basis of Borrelia Pathogenesis, National Institutes of Health, R37 AI24424-15 (2001-2011); current year funding of $250,000 direct costs (MERIT award).
(2) Biology and Control of Lyme disease Borrelia, National Institutes of Health RO1 AI37248-06 (2000-2005); current year funding of $225,000 direct costs.
(3) Transmission blocking vaccines against arthropod vectors, Senior Scholar in Global Infectious Diseases, Ellison Medical Foundation (2001-2005); current year funding of $150,000 direct costs.